Abstract
We analyzed the ApoE genotype in patients with genetic prion diseases (gPD) with respect to family history (FH) of dementia/prion disease (PD) compared to non-demented controls. Fifty-nine gPD patients and 51 sex-/age-matched controls were included. A positive FH of dementia and PD (PFH) were evaluated. The prion protein gene (PRNP) codon 129 and ApoE genotype were determined by polymerase chain reaction (PCR). The frequency of FH of neurodegenerative disorder/prion disease/dementia varied in different PRNP mutations. PFH was found in 87% of D178N patients, but was rarer in others. Although the ApoE genotype distribution was not significantly different between gPD patients and controls, the protective E2 alleles were more frequent in controls than in patients without a PFH and even less frequent in those with a PFH (18, 16, and 11%). E4 alleles as a risk factor of Alzheimer’s disease were more common in controls and patients with a PFH than in those without PFH (25, 21, and 13%). No effect of the codon 129 genotype was detected. Only about two-thirds of gPD patients had PFH of PD, while in one-third, PFH of slowly progressive dementia was reported. Underreporting of PFH of gPD may play a role; however, the varying PFH frequency across various mutations is not explained by this factor only.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alpérovitch, A., Zerr, I., Pocchiari, M., et al. (1999). Codon 129 prion protein genotype and sporadic Creutzfeldt–Jakob disease. Lancet, 353, 1673–1674.
Amouyel, P., Vidal, O., Launay, J. M., & Laplanche, J. L. (1994). The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt–Jakob disease. The French research group on epidemiology of human spongiform encephalopathies. Lancet, 344, 1315–1318.
Chapman, J., Cervenakova, L., Petersen, R. B., et al. (1998). APOE in non-Alzheimer amyloidoses: Transmissible spongiform encephalopathies. Neurology, 51, 548–553.
Corder, E. H., Saunders, A. M., Risch, N. J., et al. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics, 7, 180–184.
Corder, E. H., Saunders, A. M., Strittmatter, W. J., et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science, 261, 921–923.
Davidson, Y., Gibbons, L., Purandare, N., et al. (2006). Apolipoprotein E epsilon4 allele frequency in vascular dementia. Dementia and Geriatric Cognitive Disorders, 22, 15–19.
Del Bo, R., Scarlato, M., Ghezzi, S., et al. (2006). Is M129V of PRNP gene associated with Alzheimer’s disease? A case-control study and a meta-analysis. Neurobiology of Aging, 27, 770.e1–770.e5.
Gerdes, L. U., Klausen, I. C., Sihm, I., & Faergeman, O. (1992). Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genetic Epidemiology, 9, 155–167.
Goldfarb, L. G., Brown, P., & Gajdusek, D. C. (1992).The molecular genetics of human transmissible spongiform encephalopathy. In S. B. Prusiner, J. Collinge, J. Powell, & B. Anderton (Ed.), Prion diseases of human and animals (pp. 139–153).
Huang, Y. (2006). Apolipoprotein E and Alzheimer disease. Neurology, 66, S79–S85.
Kitamoto, T, Shin, R. W., Doh-Ura, K., et al. (1992). Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt–Jakob disease. American Journal of Pathology, 140, 1285–1294.
Kovacs, G. G., Puopolo, M., Ladogana, A., et al. (2005). Genetic prion disease: the EUROCJD experience. Human Genetics, 118, 166–174.
Kovács, G. G., Trabattoni, G., Hainfellner, J. A., Ironside, J. W., Knight, R. S., & Budka, H. (2002). Mutations of the prion protein gene. Phenotypic spectrum. Journal of Neurology, 249, 1567–1582.
Kretzschmar, H. A., Ironside, J. W., DeArmond, S. J., & Tateishi, J. (1996). Diagnostic criteria for sporadic Creutzfeldt–Jakob disease. Archives of Neurology, 53, 913–920.
Ladogana, A., Puopolo, M., Croes, E. A., et al. (2005). Mortality from Creutzfeldt–Jakob disease and related disorders in Europe, Australia, and Canada. Neurology, 64, 1586–1591.
Mastrianni, J. A., Iannicola, C., Myers, R. M., DeArmond, S., & Prusiner, S. B. (1996). Mutation of the prion protein gene at codon 208 in familial Creutzfeldt–Jakob disease. Neurology, 47, 1305–1312.
Mollenhauer, B., Trenkwalder, C., von Ahsen, N., et al. (2006) Beta-amyloid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson’s disease dementia. Dementia and Geriatric Disorders, 22, 200–208.
Nakagawa, Y., Kitamoto, T., Furukawa, H., Ogomori, K., & Tateishi, J. (1995). Allelic variation of apolipoprotein E in Japanese sporadic Creutzfeldt–Jakob disease patients. Neuroscience Letters, 187, 209–211.
O’Brien, J., Ames, D., & Burns, A. (2000). Dementia. London: Arnold.
Palmer, M. S., Dryden, A. J., Hughes, J. T., & Collinge, J. (1991). Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob disease [published erratum appears in Nature 1991 Aug 8;352(6335):547] [see comments]. Nature, 352, 340–342.
Raymond, M., & Rousset, F. (1995). Population genetics software for exact tests and ecumenicism. Journal of Heredity, 86, 248–249.
Salvatore, M., Seeber, A. C., Nacmias, B., et al. (1995). Apolipoprotein E in sporadic and familial Creutzfeldt–Jakob disease. Neuroscience Letters, 199, 95–98.
Saunders, A. M., Schmader, K., Breitner, J. C., et al. (1993). Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer’s disease and in other amyloid-forming diseases [see comments]. Lancet, 342, 710–711.
Schulz-Schaeffer, W. J., Tschoke, S., Kranefuss, N., et al. (2000). The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. American Journal of Pathology, 156, 51–56.
Van Everbroeck, B., Green, A., Pals, P., Martin, J. J., & Cras, P. (1999). Decreased levels of amyloid-beta 1-42 in cerebrospinal fluid of Creutzfeldt–Jakob disease patients. Journal of Alzheimers Disease, 1, 419–424.
WHO (1998). Human transmissible spongiform encephalopathies. Weekly Epidemiological Record, 47, 361–365.
Zannis, V. I., Just, P. W., & Breslow, J. L. (1981). Human apolipoprotein E isoprotein subclasses are genetically determined. American Journal of Human Genetics, 33, 11–24.
Zarranz, J. J., Digon, A., Atares, B., et al. (2005). Phenotypic variability in familial prion diseases due to the D178N mutation. Journal of Neurology, Neurosurgery and Psychiatry, 76, 1491–1496.
Zerr, I., Helmhold, M., Poser, S., Armstrong, V. W., & Weber, T. (1996). Apolipoprotein E phenotype frequency and cerebrospinal fluid concentration are not associated with Creutzfeldt–Jakob disease. Archives of Neurology, 53, 1233–1238.
Zerr, I., Pocchiari, M., Collins, S., et al. (2000). Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease. Neurology, 55, 811–815.
Acknowledgement
We thank Ms. Bodemer, Ms. Ciesielczyk, Ms. Hartung, Ms. Henn, and Ms. Staniszewski for technical assistance. The assistance of Ms. Ehrlich is gratefully acknowledged. This study was supported by grants from the Federal Ministry of Health and Social Security (325-4471-02/15), the European Commission (QLG3-CT-2002-81606), and the Federal Ministry of Education and Research (01GI0301).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krasnianski, A., von Ahsen, N., Heinemann, U. et al. ApoE Distribution and Family History in Genetic Prion Diseases in Germany. J Mol Neurosci 34, 45–50 (2008). https://doi.org/10.1007/s12031-007-9001-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-007-9001-2